Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Semin Nephrol ; 43(4): 151438, 2023 Jul.
Article in English | MEDLINE | ID: mdl-37951795

ABSTRACT

The global prevalence of primary hypertension has been increasing both in children and in the adolescent and adult populations and can be attributed to changes in lifestyle factors with an obesity epidemic, increased salt consumption, and sedentary lifestyles. Childhood blood pressure is the strongest predictor of adult hypertension. Although hypertension in adults is associated strongly with an increased risk for cardiovascular disease, chronic kidney disease, and mortality, outcomes in children are defined less clearly. In adults, major guidelines agree on a threshold of less than 120/80 mm Hg as the optimal blood pressure (BP) and recommend a target of less than 130/80 mm Hg for treatment in most cases. In children, international pediatric guidelines recommend using thresholds based on the normative distribution of BP in healthy normal-weight children. Out-of-office BP assessment is extremely useful for confirming the diagnosis of hypertension and monitoring response to treatment. Lifestyle modifications are instrumental whether coupled or not with pharmacologic management. New agents such as nonsteroidal mineralocorticoid-receptor antagonists, aminopeptidase A inhibitors, aldosterone synthase inhibitors, and dual endothelin antagonists hold significant promise for resistant hypertension. The transition from pediatric to adult care can be challenging and requires careful planning and effective coordination within a multidisciplinary team that includes patients and their families, and pediatric and adult providers.


Subject(s)
Cardiovascular Diseases , Hypertension , Transition to Adult Care , Adult , Adolescent , Humans , Child , Antihypertensive Agents/therapeutic use , Hypertension/diagnosis , Hypertension/drug therapy , Cardiovascular Diseases/etiology , Blood Pressure , Blood Pressure Monitoring, Ambulatory/adverse effects
2.
Clin Neurol Neurosurg ; 172: 120-123, 2018 09.
Article in English | MEDLINE | ID: mdl-29990959

ABSTRACT

Posterior reversible encephalopathy syndrome or PRES is a proposed cliniconeuroradiological entity that is characterized by headache, confusion, seizure, cortical visual disturbances or even blindness and, to a lesser extent, focal neurological signs. The etiology of this entity includes a sudden increase in blood pressure, renal failure, immunosuppressive drugs, infections, and intravenous immunoglobulin (IVIG). Classically, magnetic resonance imaging (MRI) findings show a symmetric reversible vasogenic edema in the parietooccipital lobes. PRES can involve the brainstem and cerebellum and sometimes can leave irreversible lesions but it can also recur, which is a very rare presentation. In this article, we report a case of recurrent PRES with cerebellar involvement associated with non-communicating hydrocephalus in a 2-year-old child with renal failure on peritoneal dialysis after receiving Etoposide for macrophage activation syndrome.


Subject(s)
Cerebellum/surgery , Hydrocephalus/surgery , Posterior Leukoencephalopathy Syndrome/surgery , Acute Disease , Brain Stem/surgery , Cerebellum/pathology , Child, Preschool , Humans , Hydrocephalus/complications , Magnetic Resonance Imaging/adverse effects , Male , Posterior Leukoencephalopathy Syndrome/diagnosis , Recurrence , Seizures/complications , Seizures/surgery
SELECTION OF CITATIONS
SEARCH DETAIL
...